glp-1 news today 2025-10-16 trends 2025: real-world data, patient outcomes & future therapies Compound versions of GLP-1 drugs

Advanced Delivery Systems Liposomal glutathione is a big step forward for taking something by mouth

The therapy is minimally invasive, and the risk of side effects is low when used appropriately

For this reason, the experts at Peptides.org set out to rectify this common setback

It could clog up the trabecular meshwork (drainage system of the eye) or accumulate in other parts of the eye, causing an increase in pressure

While it is important to note that most evidence remains preclinical, the breadth and consistency of findings across different research models provides a strong foundation for understanding the compound therapeutic potential

Some models also report improved total antioxidant capacity (TAC) and normalization of inflammatory cytokine levels